Genetic and environmental underpinnings to age-related ocular diseases.

Age-related macular degeneration (AMD), cataract, glaucoma and diabetic retinopathy are common causes of visual loss. Both environmental and genetic factors contribute to the development of these diseases. The modifiable factors related to some of these age-related and visually threatening diseases are smoking, obesity, and dietary factors, and a cardiovascular risk profile. Many common and a few rare genetic factors are associated with AMD. The role of genetic variants for the other diseases are less clear. Interactions between environmental, therapeutic, and genetic factors are being explored. Knowledge of genetic risk and environmental factors, especially for AMD, has grown markedly over the past 2.5 decades and has led to some sight-saving approaches in preventive management.

[1]  Sivakumar Gowrisankar,et al.  Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration , 2013, Nature Genetics.

[2]  Gabriëlle H S Buitendijk,et al.  A functional variant in the CFI gene confers a high risk of age-related macular degeneration , 2013, Nature Genetics.

[3]  Cynthia A. Toth,et al.  Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. , 2013, JAMA.

[4]  B. Rosner,et al.  Dietary omega-3 fatty acids, other fat intake, genetic susceptibility, and progression to incident geographic atrophy. , 2013, Ophthalmology.

[5]  Johanna M Seddon,et al.  Validation of a prediction algorithm for progression to advanced macular degeneration subtypes. , 2013, JAMA ophthalmology.

[6]  Gabriëlle H S Buitendijk,et al.  Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.

[7]  J. P. McCoy,et al.  Hypomethylation of the IL17RC promoter associates with age-related macular degeneration. , 2012, Cell reports.

[8]  Juan Ye,et al.  Smoking and risk of age-related cataract: a meta-analysis. , 2012, Investigative ophthalmology & visual science.

[9]  M. Daly,et al.  Prospective assessment of genetic effects on progression to different stages of age-related macular degeneration using multistate Markov models. , 2012, Investigative ophthalmology & visual science.

[10]  Johanna M Seddon,et al.  Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. , 2011, Ophthalmology.

[11]  Sivakumar Gowrisankar,et al.  A rare penetrant mutation in CFH confers high risk of age-related macular degeneration , 2011, Nature Genetics.

[12]  M. Daly,et al.  Candidate gene association study for diabetic retinopathy in persons with type 2 diabetes: the Candidate gene Association Resource (CARe). , 2011, Investigative ophthalmology & visual science.

[13]  B. Rosner,et al.  Smoking, dietary betaine, methionine, and vitamin D in monozygotic twins with discordant macular degeneration: epigenetic implications. , 2011, Ophthalmology.

[14]  Aaron Y. Lee,et al.  Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.

[15]  Aaron Y. Lee,et al.  Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC) , 2010, Proceedings of the National Academy of Sciences.

[16]  B. Rosner,et al.  Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.

[17]  R. Klein,et al.  Forecasting age-related macular degeneration through 2050. , 2009, JAMA.

[18]  Johanna M Seddon,et al.  Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. , 2009, Investigative ophthalmology & visual science.

[19]  E. Souied,et al.  [Epidemiology of age related macular degeneration]. , 2009, Journal Francais d'Ophtalmologie.

[20]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[21]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[22]  Johanna M Seddon,et al.  The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.

[23]  R. Milton,et al.  C-reactive protein and homocysteine are associated with dietary and behavioral risk factors for age-related macular degeneration. , 2006, Nutrition.

[24]  A. Ramé [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[25]  B. Rosner,et al.  CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. , 2006, Human heredity.

[26]  Johanna M Seddon,et al.  The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.

[27]  P. Jong Prevalence of age-related macular degeneration in the United States. , 2004 .

[28]  M. C. Leske,et al.  Prevalence of open-angle glaucoma among adults in the United States. , 2004, Archives of ophthalmology.

[29]  N. Rifai,et al.  Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.

[30]  Ronald Klein,et al.  The epidemiology of age-related macular degeneration. , 2004, American journal of ophthalmology.

[31]  Harold Snieder,et al.  Genetic influence on early age-related maculopathy: a twin study. , 2002, Ophthalmology.

[32]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[33]  C. Mangione,et al.  Influence of age-related maculopathy on visual functioning and health-related quality of life. , 1999, American journal of ophthalmology.

[34]  J. Seddon,et al.  Do age-related macular degeneration and cardiovascular disease share common antecedents? , 1999, Ophthalmic epidemiology.

[35]  Lawrence A. Yannuzzi,et al.  Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .

[36]  R Hiller,et al.  Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.